Braunstein retiring as Idorsia CMO

After 15 years at Idorsia Ltd. (SIX:IDIA), Guy Braunstein will retire as CMO by the end of this month, after which he will continue as an adviser to the company. Antonio Olivieri will succeed Braunstein while remaining head of global medical affairs.

Lys Therapeutics S.A.S. named Michel Vounatsos as chair. Vounatsos was CEO of Biogen Inc. (NASDAQ:BIIB) in 2017-22. Lys is developing neurodegenerative and neurovascular diseases...